Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 226,160,421 papers from all fields of science
Search
Sign In
Create Free Account
foscarnet sodium
Known as:
Trisodium Phosphonoformate
, Phosphonoformate Trisodium
, Trisodium Salt, Foscarnet
Expand
The trisodium salt of a synthetic organic analogue of inorganic pyrophosphate with antiviral activity. Foscarnet selectively blocks the pyrophosphate…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
4 relations
250 ML foscarnet sodium 24 MG/ML Injection [Foscavir]
Foscarnet
Foscarnet Sodium Hexahydrate
Narrower (1)
Foscavir
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
Determination and pharmacokinetic profile of liposomal foscarnet in rabbit ocular tissues after intravitreal administration.
Carmen Claro
,
R. Ruiz
,
+4 authors
M. J. Lucero
Experimental Eye Research
2009
Corpus ID: 6956916
1999
1999
Intravitreal pharmacokinetics in rabbits of the foscarnet lipid prodrug: 1-O-octadecyl-sn-glycerol-3-phosphonoformate (ODG-PFA).
L. Cheng
,
K. Hostetler
,
+4 authors
W. Freeman
Current Eye Research
1999
Corpus ID: 36332783
PURPOSE To evaluate the intraocular distribution and metabolism of the lipid prodrug of foscarnet, 1-O-octadecyl-sn-glycerol-3…
Expand
1997
1997
Foscarnet for prevention of cytomegalovirus infection in allogeneic marrow transplant recipients unable to receive ganciclovir
C. Ippoliti
,
A. Morgan
,
+8 authors
D. Przepiorka
Bone Marrow Transplantation
1997
Corpus ID: 1607886
Cytomegalovirus (CMV) disease can be prevented by administration of ganciclovir prophylactically post-transplant. However, up to…
Expand
1994
1994
The development of cytomegalovirus encephalitis in AIDS patients receiving ganciclovir.
Stephen M. Berman
,
Ronald C. Kim
American Journal of Medicine
1994
Corpus ID: 32635196
1989
1989
Foscarnet therapy in chronic hepatitis B virus e antigen carriers
V. Bain
,
H. Daniels
,
A. Chanas
,
G. Alexander
,
Roger Williams
Journal of Medical Virology
1989
Corpus ID: 10793167
Foscarnet (trisodium phosphonoformate) is a novel antiviral agent that inhibits viral‐specific DNA polymerase. In the present…
Expand
1988
1988
Treatment of cytomegalovirus disease.
Morris Dj
New England Journal of Medicine
1988
Corpus ID: 23267087
Highly Cited
1986
Highly Cited
1986
Foscarnet decreases serum and liver duck hepatitis B virus DNA in chronically infected ducks.
A. Sherker
,
K. Hirota
,
M. Omata
,
K. Okuda
Gastroenterology
1986
Corpus ID: 41306174
1984
1984
Class‐specific antibody responses to early and late antigens of varicella and herpes simplex viruses
N. Schmidt
,
D. Gallo
Journal of Medical Virology
1984
Corpus ID: 36585366
Antibody responses to early antigens of varicella‐zoster virus (VZV), simian varicella virus, and herpes simplex virus types 1…
Expand
1982
1982
Therapeutic effects of foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus type 1 in guinea pigs.
S. Alenius
,
M. Berg
,
F. Broberg
,
K. Eklind
,
B. Lindborg
,
Bo Öberg
Journal of Infectious Diseases
1982
Corpus ID: 42867816
The therapeutic effects of topically applied foscarnet sodium and acyclovir on cutaneous infections due to herpes simplex virus…
Expand
1978
1978
Reversible Effects on Cellular Metabolism and Proliferation by Trisodium Phosphonoformate
K. Stenberg
,
A. Larsson
Antimicrobial Agents and Chemotherapy
1978
Corpus ID: 45475138
The antiviral compound trisodium phosphonoformate (PFA), which inhibits herpesvirus multiplication by 50% at a concentration of…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE